Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2012 06:30 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. Closes Previously Announced $5 Million Financing

BOTHELL, WA--(Marketwire - Jan 6, 2012) - Marina Biotech, Inc. (NASDAQ: MRNAD), a leading oligonucleotide-based drug discovery and development company, announced today that it has completed the...
January 03, 2012 06:30 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. to Present at Biotech Showcase 2012

BOTHELL, WA--(Marketwire - Jan 3, 2012) - Marina Biotech, Inc. (NASDAQ: MRNAD), a leading oligonucleotide-based drug discovery and development company, announced today that it will present at...
December 23, 2011 06:45 ET | Source: Marina Biotech, Inc.

Marina Biotech and Mirna Therapeutics Announce License Agreement for the Development of microRNA-Based Therapeutics

BOTHELL, WA and AUSTIN, TX--(Marketwire - Dec 23, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, and Mirna Therapeutics, Inc....
December 23, 2011 06:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces $5 Million Private Placement

BOTHELL, WA--(Marketwire - Dec 23, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that it has entered into a $5...
November 30, 2011 07:30 ET | Source: Marina Biotech, Inc.

Marina Biotech to Remain Listed on The NASDAQ Global Market

BOTHELL, WA--(Marketwire - Nov 30, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that the NASDAQ Listing...
November 29, 2011 07:30 ET | Source: Marina Biotech, Inc.

Marina Biotech and Debiopharm SA Achieve Key Pre-Clinical Milestone in Bladder Cancer Program

BOTHELL, WA--(Marketwire - Nov 29, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, today announced that the Marina/Debiopharm...
November 17, 2011 07:30 ET | Source: Marina Biotech

Marina Biotech Granted Patent Rights in China for Intranasal Insulin Delivery Formulations

BOTHELL, WA--(Marketwire - Nov 17, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, reported that the State Intellectual Property...
November 10, 2011 07:30 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. Announces Third Quarter 2011 Financial Results

BOTHELL, WA--(Marketwire - Nov 10, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, today reported financial results for the...
November 02, 2011 07:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Demonstrates That Its Novel UsiRNA Oligonucleotide Abrogates Cytotoxicity Resulting From microRNA-Like Off-Target Activity

BOTHELL, WA--(Marketwire - Nov 2, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, reported significant reduction of microRNA-like...
October 19, 2011 17:30 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. to Present at The 10th Annual BIO Investor Forum

BOTHELL, WA--(Marketwire - Oct 19, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that it will present at The...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right